Biotron Limited (BITRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0027
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
Biotron Revenue
Biotron had revenue of 1.81M AUD in the half year ending December 31, 2024, with 26.77% growth. This brings the company's revenue in the last twelve months to 1.81M, up 10.30% year-over-year. In the fiscal year ending June 30, 2024, Biotron had annual revenue of 1.65M with 14.94% growth.
Revenue (ttm)
1.81M AUD
Revenue Growth
+10.30%
P/S Ratio
2.26
Revenue / Employee
604.83K AUD
Employees
3
Market Cap
2.54M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.65M | 213.83K | 14.94% |
Jun 30, 2023 | 1.43M | -127.24K | -8.16% |
Jun 30, 2022 | 1.56M | 96.58K | 6.61% |
Jun 30, 2021 | 1.46M | 658.92K | 82.05% |
Jun 30, 2020 | 803.03K | -269.81K | -25.15% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |